Mylan recalls all batches of blood pressure drug in U.S.

Dec 04, 2018

Mylan will be expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots.

The company recalled some batches two weeks ago but is now recalling 104 additional lots after discovering that the valsartan-containing products had traces of an impurity.

Last month, the FDA stopped imports of drug ingredients or medicines from Zhejiang Huahai Pharmaceuticals, a Chinese bulk manufacturer of valsartan.

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments